Maud Kamal

13PUBLICATIONS
103CO-AUTHORS
Molecular targetsPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 15, 2026
SHIVA02 Trial: Using Patients as Their Own Controls to Assess Efficacy of Therapies Based on Molecular Profiling in Patients with Refractory Cancer.

|Jun 09, 2026
Molecular Tumor Boards clinical impact on patient care and structural features: A systematic review and meta-analysis.

|Nov 12, 2025
An Extracellular Matrix-Producing Subset of Cancer-Associated Fibroblasts Drives Chemoresistance in Breast Cancer via SRC Activation and G0S2 Upregulation.

Isabella Hofer, Yann Kieffer, Arianna Mencattini

|Dec 02, 2024
Noninvasive Multicancer Detection Using DNA Hypomethylation of LINE-1 Retrotransposons.

Marc Michel, Maryam Heidary, Anissa Mechri

|Oct 04, 2024
The genomic and transcriptomic landscape of metastastic urothelial cancer.

Yohann Loriot, Maud Kamal, Laurene Syx

|Aug 01, 2024
Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors.

Marie-Paule Sablin, Pierre Gestraud, Sarah Flora Jonas

Pageof 3

Frequent Collaborators

9 joint publications

Christophe Le Tourneau

5 joint publications

Nicolas Servant

4 joint publications

Yves Allory

3 joint publications

Fabrice André